top of page
CORPORATE PROFILE
 
We are late pre-clinical stage oncology drug development company developing new revolutionary therapies against cancer and diabetes. We have a vision of changing cancer treatment, addressing resistance development, metastasis, and patient relapse. Felicitex owns proprietary sets of clinical candidates: selective and specific small molecule inhibitors.​Principals have unique expertise in the development of cancer therapeutics, extensive Pharma and business development experience. Felicitex has developed multiple collaborations with leading academic and commercial institutions.

 © 2019 by Felicitex Therapeutics, Inc »«                                                        

Skydivers

Felicitex Therapeutics Inc.

27 Strathmore Rd.

Natick, MA 01760

(919) 213-0025

bottom of page